Panacea Biotec P/B Ratio
Panacea Biotec (PANACEABIO) P/B ratio is 4.11 (High), book value per share ₹1391.67 vs Healthcare average P/B of -0.33 — Very High - Significant premium, high growth expectations or speculative. Review PANACEABIO earnings multiple to evaluate earnings-based valuation against sector peers.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
PANACEABIO P/B Ratio — Valuation Insights & Book Value Analysis
Panacea Biotec price-to-book ratio interpretation, valuation status and historical context — current P/B 4.11 (High). For live price, earnings yield and the full fundamental profile, see Panacea Biotec share price today.
- Stock appears overvalued with PB of 4.11, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 1626.9% above historical average
- Trading at premium to sector average PB of -0.33
Panacea Biotec P/B Ratio Historical Trend
PANACEABIO annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. View PANACEABIO 52-week performance for the annual high/low range and current price position.
PANACEABIO Historical P/B Ratio — Book Value Per Share & Year-End Price
Panacea Biotec annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 0.4 | ₹1391.67 | ₹551.20 | ₹835 | Low |
| 2025 | 0.27 | ₹1385.0 | ₹376.30 | ₹831 | Low |
| 2024 | 0.3 | ₹1396.67 | ₹418.60 | ₹838 | Low |
| 2023 | 0.12 | ₹1400.0 | ₹167.90 | ₹840 | Low |
| 2022 | 0.1 | ₹1456.67 | ₹142.05 | ₹874 | Low |
PANACEABIO vs Healthcare Peers — P/B Ratio Comparison
Panacea Biotec P/B 4.11 vs Healthcare average -0.33, median 0.6 — range -17.45–1.11.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -17.45 | ₹21 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Parmax Pharma | PARMAX | -4.18 | ₹29 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.34 | ₹75 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.88 | ₹132 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.56 | ₹50 | Low |